Clinical Trials Directory

Trials / Completed

CompletedNCT06598995

Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy

The Association Between Myocardial Bridging and Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy

Status
Completed
Phase
Study type
Observational
Enrollment
968 (actual)
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigated the impact of myocardial bridging (MB) and its characteristics on preoperative atrial fibrillation and survival in patients with obstructive hypertrophic cardiomyopathy (oHCM). We recruited 968 consecutive patients with oHCM who underwent myectomy at our institution between January 2015 and December 2019, including 144 patients with MB and 824 patients without MB. All patients received angiography before surgery. The diagnosis of preoperative atrial fibrillation was based on 12-lead electrocardiography, 24-hour Holter electrocardiography, or in-hospital electrocardiogram monitoring, which was extracted from patients' medical records. Surgical details and follow-up data were also collected.

Conditions

Interventions

TypeNameDescription
PROCEDURECoronary artery bypass grafting or unroofingPatients had an MB with \>75% compression degree would receive coronary artery bypass grafting, and those who underwent unroofing may had a depth of MB \< 5mm (whether deal with these MB with a depth \<5mm depends on the surgeon and the period time of patients received a surgery).

Timeline

Start date
2022-01-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06598995. Inclusion in this directory is not an endorsement.